PATRICIA CASTRO to Immunoconjugates
This is a "connection" page, showing publications PATRICIA CASTRO has written about Immunoconjugates.
Connection Strength
0.393
-
Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors. Cancer Res Commun. 2025 Nov 01; 5(11):2066-2078.
Score: 0.229
-
Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody-Drug Conjugate and Immune Checkpoint Blockade. Cancer Res. 2021 04 01; 81(7):1775-1787.
Score: 0.164